As weve discussed, Semaglutide is an analogue of GLP-1
About the AAO Innovation and Transformation Fund By building, partnering or investing, the AAO Innovation and Transformation Fund can be used to develop new products and services for orthodontists and patients and will drive non-dues revenue for the association
Recently, a real-world study showing association between incretin-based therapy and changes in taste perception with GLP-1 or dual GLP-1/GIP-RAs usage for around 40 weeks reported that independently to weight loss, there was an increase in sweet perception intensity up to 4.7 times and salt perception up to 3.2 times in around 20% of the participants, resulting as well in earlier satiety, and reduction of hunger and craving due to a major sensibilization to both flavors with any of these medication, although they did not mention further impact in weight loss or BMI change (170)
If this is not possible, the patient should be closely monitored
Every batch is tested by NABL-accredited laboratories.
